Article
Integration of MRI radiomics and germline genetics to predict the IDH mutation status of gliomas
16 Jun 2025
Abstract excerpt
The molecular profiling of gliomas for isocitrate dehydrogenase ( IDH ) mutations currently relies on resected tumor samples, highlighting the need for non-invasive, preoperative biomarkers. We investigated the integration of glioma polygenic risk scores (PRS) and radiographic features for prediction of IDH mutation status. We used 256 radiomic features, a glioma PRS and demographic information in 158 glioma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
